# Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition

> **NCT01160029** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 58 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nateglinide

## Key facts

- **NCT ID:** NCT01160029
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2010-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01160029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01160029, "Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01160029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*